One Patient Profile Emerges as Extra-Well Suited for Extra-Long DAPT After PCI

(MedPage Today) -- There was strong evidence for extending dual antiplatelet therapy (DAPT) beyond the standard 12 months in selected patients with multivessel coronary artery disease (CAD), the DAPT-MVD trial found.
These were nonelderly patients...